CEFEPIME FOR INJECTION USP
Google image searchProduct monograph
Active ingredient
cefepime (cefepime hydrochloride), 2 G/VIAL
DIN: 02499096
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIALS
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 25-MAY-2022
ATC:
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J01D — OTHER BETA-LACTAM ANTIBACTERIALS (ATC, ATC/DDD)
- J01DE — Fourth-generation cephalosporins (ATC, ATC/DDD)
- J01DE01 — CEFEPIME (ATC/DDD)
Reference brand drug: Maxipime
Pharmaceutical standard: USP
